135 related articles for article (PubMed ID: 33705578)
1. Longitudinal follow-up of a novel classification system for irritable bowel syndrome: natural history and prognostic value.
Black CJ; Yiannakou Y; Guthrie E; West R; Houghton LA; Ford AC
Aliment Pharmacol Ther; 2021 May; 53(10):1126-1137. PubMed ID: 33705578
[TBL] [Abstract][Full Text] [Related]
2. A Novel Method to Classify and Subgroup Patients With IBS Based on Gastrointestinal Symptoms and Psychological Profiles.
Black CJ; Yiannakou Y; Guthrie EA; West R; Houghton LA; Ford AC
Am J Gastroenterol; 2021 Feb; 116(2):372-381. PubMed ID: 33110014
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of patients with Rome IV-defined versus physician-diagnosed irritable bowel syndrome: Longitudinal follow-up study.
Goodoory VC; Craig OF; Gracie DJ; Black CJ; Ford AC
Neurogastroenterol Motil; 2022 Jun; 34(6):e14282. PubMed ID: 34612560
[TBL] [Abstract][Full Text] [Related]
4. Natural History and Disease Impact of Rome IV Vs Rome III Irritable Bowel Syndrome: A Longitudinal Follow-Up Study.
Goodoory VC; Houghton LA; Yiannakou Y; Black CJ; Ford AC
Clin Gastroenterol Hepatol; 2022 Mar; 20(3):569-577.e3. PubMed ID: 33957271
[TBL] [Abstract][Full Text] [Related]
5. Symptom Stability in Rome IV vs Rome III Irritable Bowel Syndrome.
Barberio B; Houghton LA; Yiannakou Y; Savarino EV; Black CJ; Ford AC
Am J Gastroenterol; 2021 Feb; 116(2):362-371. PubMed ID: 33009062
[TBL] [Abstract][Full Text] [Related]
6. Latent class analysis does not support the existence of Rome IV functional bowel disorders as discrete entities.
Black CJ; Houghton LA; Ford AC
Neurogastroenterol Motil; 2022 Nov; 34(11):e14391. PubMed ID: 35531932
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of, and natural history among, individuals with Rome IV functional bowel disorders.
Goodoory VC; Houghton LA; Black CJ; Ford AC
Neurogastroenterol Motil; 2022 May; 34(5):e14268. PubMed ID: 34532930
[TBL] [Abstract][Full Text] [Related]
8. Novel Symptom Subgroups in Individuals With Irritable Bowel Syndrome Predict Disease Impact and Burden.
Black CJ; Ng CE; Goodoory VC; Ford AC
Clin Gastroenterol Hepatol; 2024 Feb; 22(2):386-396.e10. PubMed ID: 36858142
[TBL] [Abstract][Full Text] [Related]
9. Overlap of Rome IV Irritable Bowel Syndrome and Functional Dyspepsia and Effect on Natural History: A Longitudinal Follow-Up Study.
Barberio B; Yiannakou Y; Houghton LA; Black CJ; Savarino EV; Ford AC
Clin Gastroenterol Hepatol; 2022 Feb; 20(2):e89-e101. PubMed ID: 33839276
[TBL] [Abstract][Full Text] [Related]
10. Natural history and impact of irritable bowel syndrome-type symptoms in inflammatory bowel disease during 12 months of longitudinal follow-up.
Barberio B; Fairbrass KM; Gracie DJ; Ford AC
Neurogastroenterol Motil; 2024 Feb; 36(2):e14713. PubMed ID: 37994228
[TBL] [Abstract][Full Text] [Related]
11. Impact of Psychological Comorbidity on the Prognosis of Irritable Bowel Syndrome.
Goodoory VC; Mikocka-Walus A; Yiannakou Y; Houghton LA; Black CJ; Ford AC
Am J Gastroenterol; 2021 Jul; 116(7):1485-1494. PubMed ID: 33840729
[TBL] [Abstract][Full Text] [Related]
12. Mixture model analysis identifies irritable bowel syndrome subgroups characterised by specific profiles of gastrointestinal, extraintestinal somatic and psychological symptoms.
Polster A; Van Oudenhove L; Jones M; Öhman L; Törnblom H; Simrén M
Aliment Pharmacol Ther; 2017 Sep; 46(5):529-539. PubMed ID: 28671338
[TBL] [Abstract][Full Text] [Related]
13. Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients.
Mikocka-Walus A; Turnbull D; Moulding N; Wilson I; Andrews JM; Holtmann G
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1137-43. PubMed ID: 18070012
[TBL] [Abstract][Full Text] [Related]
14. Novel Irritable Bowel Syndrome Subgroups are Reproducible in the Global Adult Population.
Black CJ; Houghton LA; West RM; Bangdiwala SI; Palsson OS; Sperber AD; Ford AC
Clin Gastroenterol Hepatol; 2024 Jun; ():. PubMed ID: 38876193
[TBL] [Abstract][Full Text] [Related]
15. Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study.
Vork L; Weerts ZZRM; Mujagic Z; Kruimel JW; Hesselink MAM; Muris JWM; Keszthelyi D; Jonkers DMAE; Masclee AAM
Neurogastroenterol Motil; 2018 Feb; 30(2):. PubMed ID: 28804974
[TBL] [Abstract][Full Text] [Related]
16. Quantifying Rome symptoms for diagnosis of the irritable bowel syndrome.
Chang JY; Almazar AE; Richard Locke G; Larson JJ; Atkinson EJ; Talley NJ; Saito YA
Neurogastroenterol Motil; 2018 Sep; 30(9):e13356. PubMed ID: 29701271
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population-based study.
Koloski NA; Jones M; Young M; Talley NJ
Aliment Pharmacol Ther; 2015 May; 41(9):856-66. PubMed ID: 25736433
[TBL] [Abstract][Full Text] [Related]
18. Determinants and frequency of irritable bowel syndrome in a German sample.
Althaus A; Broicher W; Wittkamp P; Andresen V; Lohse AW; Löwe B
Z Gastroenterol; 2016 Mar; 54(3):217-25. PubMed ID: 27043884
[TBL] [Abstract][Full Text] [Related]
19. Subtyping irritable bowel syndrome using cluster analysis: a systematic review.
Zarei D; Saghazadeh A; Rezaei N
BMC Bioinformatics; 2023 Dec; 24(1):478. PubMed ID: 38102564
[TBL] [Abstract][Full Text] [Related]
20. Influence of psychological distress on characteristics of symptoms in patients with GERD: the role of IBS comorbidity.
Rey E; García-Alonso M; Moreno-Ortega M; Almansa C; Alvarez-Sanchez A; Díaz-Rubio M
Dig Dis Sci; 2009 Feb; 54(2):321-7. PubMed ID: 18649139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
